The University of Vermont, officially the University of Vermont and State Agricultural College, is a public land-grant research university in Burlington, Vermont.

During the past decade, University of Vermont conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 117 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 67 clinical trials were completed. i.e. 97.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Vermont" #1 sponsor was "National Cancer Institute (NCI)" with 88 trials, followed by "University of Vermont" with 61 trials sponsored, "Children's Oncology Group" with 50 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "National Center for Research Resources (NCRR)" with 13 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Vermont" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 16 trials as a collaborator, "University of Vermont" with 11 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 196 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "University of Vermont" are "Recurrent Neuroblastoma" (18 trials), "Refractory Neuroblastoma" (14 trials), "Recurrent Malignant Solid Neoplasm" (13 trials), "Recurrent Osteosarcoma" (13 trials) and "Refractory Malignant Solid Neoplasm" (13 trials). Many other conditions were trialed in "University of Vermont" in a lesser frequency.

Most popular intervention types in "University of Vermont" are "Drug" (219 trials), "Other" (141 trials), "Biological" (78 trials), "Procedure" (58 trials) and "Radiation" (37 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (77 trials), "Quality-of-Life Assessment" (38 trials), "Placebo" (36 trials), "Cyclophosphamide" (35 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.

The vast majority of trials in "University of Vermont" are 305 trials for "All" genders, 35 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "University of Vermont". undefined are not yet recruiting, 66 are recruiting, 95 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 145 completed trials in University of Vermont, 4 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Vermont, 21 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 136 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 47 trials that are defined as “Not Applicable".

University of Vermont has several departments that took part in Clinical trials: "University of Vermont, Division of General Internal Medicine" - 2 trials, "University of Vermont, Dept of Surgery" - 2 trials, "University of Vermont, Psychology Department" - 2 trials